News

Protecting Subjects: The IRBs Next Steps

SITES : Incorporating Standard of Care in Study Budgets Benefits of CTMS at the Investigative Site Also in this issue : FDA Transparency Efforts to Impact Research, Survey Assesses Europe?s Clinical Trials Directive, Tapping into the Potential of Pharmacists, Biosimilars Make Headway in the U.S.

Updates on Osteoporosis including Amgen and Prolia trials.

Do Sites Prefer a Sponsor Company or CRO to Run Their Clinical Trial?

Industry news focusing on the people and organizations who work in the clinical trials profession.